These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
159 related items for PubMed ID: 10762120
1. Successful treatment of Candida glabrata endophthalmitis with amphotericin B lipid complex (ABLC). Darling K, Singh J, Wilks D. J Infect; 2000 Jan; 40(1):92-4. PubMed ID: 10762120 [Abstract] [Full Text] [Related]
2. Worsening of endogenous Candida albicans endophthalmitis during therapy with intravenous lipid complex amphotericin B. Virata SR, Kylstra JA, Brown JC, Wohl DA, Cohen MS. Clin Infect Dis; 1999 May; 28(5):1177-8. PubMed ID: 10452666 [No Abstract] [Full Text] [Related]
3. Subtherapeutic ocular penetration of caspofungin and associated treatment failure in Candida albicans endophthalmitis. Gauthier GM, Nork TM, Prince R, Andes D. Clin Infect Dis; 2005 Aug 01; 41(3):e27-8. PubMed ID: 16007519 [Abstract] [Full Text] [Related]
4. Amphotericin B lipid complex for neonatal invasive candidiasis. Adler-Shohet F, Waskin H, Lieberman JM. Arch Dis Child Fetal Neonatal Ed; 2001 Mar 01; 84(2):F131-3. PubMed ID: 11207232 [Abstract] [Full Text] [Related]
5. Treatment of postkeratitis fusarium endophthalmitis with amphotericin B lipid complex. Goldblum D, Frueh BE, Zimmerli S, Böhnke M. Cornea; 2000 Nov 01; 19(6):853-6. PubMed ID: 11095064 [Abstract] [Full Text] [Related]
6. Disseminated fungemia due to Candida krusei with cutaneous lesions and successful treatment by amphotericin B lipid complex and catheter removal: a case report. Hourez R, Gillard PH, Mariat P, Aoun M. Int J Infect Dis; 2002 Dec 01; 6(4):326-8. PubMed ID: 12725216 [No Abstract] [Full Text] [Related]
7. Successful treatment with liposomal amphotericin B of an intraabdomianl abscess due to Candida norvegensis associated with a Gore-Tex mesh infection. Nolla-Salas J, Torres-Rodríguez JM, Grau S, Isbert F, Torrella T, Riveiro M, Sitges-Serra A. Scand J Infect Dis; 2000 Dec 01; 32(5):560-2. PubMed ID: 11055666 [Abstract] [Full Text] [Related]
8. Biliary excretion of amphotericin B deoxycholate and amphotericin B lipid complex. Duflo F, Allaouchiche B, Chassard D. Scand J Infect Dis; 2000 Dec 01; 32(5):581. PubMed ID: 11055677 [No Abstract] [Full Text] [Related]
9. In vivo activity of amphotericin B lipid complex in immunocompromised mice against fluconazole-resistant or fluconazole-susceptible Candida tropicalis. Warn PA, Morrissey J, Moore CB, Denning DW. Antimicrob Agents Chemother; 2000 Oct 01; 44(10):2664-71. PubMed ID: 10991841 [Abstract] [Full Text] [Related]
10. Treatment of Candida infections with amphotericin B lipid complex. Ito JI, Hooshmand-Rad R. Clin Infect Dis; 2005 May 01; 40 Suppl 6():S384-91. PubMed ID: 15809924 [Abstract] [Full Text] [Related]
11. Amphotericin B lipid complex (ABLC)-associated hypertension: case report and review. Rowles DM, Fraser SL. Clin Infect Dis; 1999 Dec 01; 29(6):1564-5. PubMed ID: 10585814 [Abstract] [Full Text] [Related]
12. Successful treatment of disseminated coccidioidomycosis with amphotericin B lipid complex. Koehler AP, Cheng AF, Chu KC, Chan CH, Ho AS, Lyon DJ. J Infect; 1998 Jan 01; 36(1):113-5. PubMed ID: 9515680 [Abstract] [Full Text] [Related]
13. Amphotericin B lipid complex for the treatment of patients with acute leukemia and hepatosplenic candidiasis. Sallah S, Semelka RC, Sallah W, Vainright JR, Philips DL. Leuk Res; 1999 Nov 01; 23(11):995-9. PubMed ID: 10576503 [Abstract] [Full Text] [Related]
14. Eradication of severe neonatal systemic candidiasis with amphotericin B lipid complex. Knoppert DC, Salama HE, Lee DS. Ann Pharmacother; 2001 Sep 01; 35(9):1032-6. PubMed ID: 11573851 [Abstract] [Full Text] [Related]
15. Life-threatening adverse event after amphotericin B lipid complex treatment in a patient treated previously with amphotericin B deoxycholate. Garnacho-Montero J, Ortiz-Leyba C, García Garmendia JL, Jiménez Jiménez F. Clin Infect Dis; 1998 Apr 01; 26(4):1016. PubMed ID: 9564508 [No Abstract] [Full Text] [Related]
16. Development of candidemia on caspofungin therapy: a case report. Cheung C, Guo Y, Gialanella P, Feldmesser M. Infection; 2006 Dec 01; 34(6):345-8. PubMed ID: 17180591 [Abstract] [Full Text] [Related]
17. Amphotericin B in the therapy of Candida glabrata endophthalmitis after penetrating keratoplasty. Grueb M, Rohrbach JM, Zierhut M. Cornea; 2006 Dec 01; 25(10):1243-4. PubMed ID: 17172909 [Abstract] [Full Text] [Related]
18. Amphotericin B lipid complex for invasive fungal infections: analysis of safety and efficacy in 556 cases. Walsh TJ, Hiemenz JW, Seibel NL, Perfect JR, Horwith G, Lee L, Silber JL, DiNubile MJ, Reboli A, Bow E, Lister J, Anaissie EJ. Clin Infect Dis; 1998 Jun 01; 26(6):1383-96. PubMed ID: 9636868 [Abstract] [Full Text] [Related]
19. Efficacy and safety of amphotericin B lipid complex injection (ABLC) in solid-organ transplant recipients with invasive fungal infections. Linden P, Williams P, Chan KM. Clin Transplant; 2000 Aug 01; 14(4 Pt 1):329-39. PubMed ID: 10945204 [Abstract] [Full Text] [Related]
20. Amphotericin B lipid complex in pediatric patients with invasive fungal infections. Walsh TJ, Seibel NL, Arndt C, Harris RE, Dinubile MJ, Reboli A, Hiemenz J, Chanock SJ. Pediatr Infect Dis J; 1999 Aug 01; 18(8):702-8. PubMed ID: 10462340 [Abstract] [Full Text] [Related] Page: [Next] [New Search]